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that adenosine may be derived from adenine In recent years there has been a tendency nucleotides which are released from damaged for less importance to be attached to purine airway cells. Indeed, adenine nucleotides are derivatives as mediators of allergic inflam-present in large quantities in the cytoplasm of mation. However, the recent work by Nyce and these cells and then converted to adenosine by Metzger 5 in which adenosine induced bron-the action of ectonucleotidase enzymes on the choconstriction is abolished by using antisense cell membranes. 12 oligodeoxynucleotides to reduce the number of Once generated, adenosine has the capacity adenosine A1 receptors in the lung of an animal to promote a large variety of responses in the model of allergic asthma, and data from a airways which are relevant to asthma. Aside number of sources which indicate that bron-from its potential role as a mediator of bronchial provocation with inhaled adenosine may choconstriction, adenosine may also function be a more precise index of disease activity than as a novel paracrine mediator that contributes conventional bronchoprovocation tests, have to various aspects of the inflammatory renow led to a resurgence of interest in the role sponse. Asthma is known to be a chronic of this purine nucleoside in asthma.
inflammatory disease associated with the In this article we will briefly review the pathological findings of cellular infiltration and putative role of adenosine as a mediator in oedema of the bronchial mucosa. In this respect airway inflammation, the current view of the adenosine may have some important actions. mechanisms of adenosine induced broncho-Adenosine causes plasma exudation and inconstriction, and the evidence for adenosine creased bronchial blood flow. 13 The ensuing bronchoprovocation as a valuable diagnostic presence of plasma proteins in the interstitium test for asthma.
produces The appreciation of the potential role of adenosine are active during inflammatory dis- To speculate further, the recent demonstration mechanisms that explains the beneficial effect of theophylline in asthma. Theophylline, which of a protective effect of inhaled heparin in AMP induced bronchoconstriction may be ascribed also acts as an adenosine receptor antagonist, has been shown to produce a greater protection to blockade of the intracellular 1,4,5-inositol triphosphate (IP3) dependent pathway of mast against adenosine-induced bronchoconstriction than against histamine-induced broncho-cell degranulation. 33 More direct evidence that mediators released constriction. 20 One difficulty with this view has been the anti-asthmatic activity of the methyl-from airway mast cells are critical for adenosine induced responses comes from a study in which xanthine phosphodiesterase inhibitor, enprofylline, which has previously been thought venous plasma histamine levels were measured after allergen and AMP challenge in a group to lack adenosine receptor antagonist activity. 21 However, it has recently been shown that this of atopic subjects. A small but significant increase in histamine levels was detected foldrug does, in fact, possess A2b receptor antagonist properties.
18 lowing adenosine challenge. 34 We have since carried out a study in which AMP was directly At present it is premature to implicate purines in the pathogenesis of asthma. Their con-instilled into a segmental airway of a group of asthmatic subjects and the segment was then tribution will only be established through the use of potent and specific adenosine antagonists lavaged to sample for mediator release. A significant increase in lavage concentrations of which are now in clinical development.
mast cell derived histamine and tryptase were observed. 35 In addition, a recent study using a model of nasal provocation with AMP indicates Mechanisms of adenosine induced bronchoconstriction that this purine nucleotide is also able to induce an immediate rise in histamine levels in the It is now more than a decade since Cushley et al 3 first reported that adenosine provoked nasal lavage fluid. 36 These studies provide strong support for the notion that a major concentration related bronchoconstriction when administered by inhalation to asthmatic component of AMP induced bronchoconstriction results from mast cell desubjects but not to normal volunteers. In addition, inhalation of its related nucleotide, granulation, probably via stimulation of cell surface purinoceptors. adenosine 5′-monophosphate (AMP), produces an almost identical effect on the airways 22 Activation of neural pathways may also contribute to the contractile airway response to as this is dephosphorylated to yield adenosine. Since these observations were made, con-these autacoids in asthma. The possibility of a reflex cholinergic component was originally siderable effort has been directed at elucidating the mechanism by which adenosine mediates indicated by data from studies in inbred rats 37 and later confirmed in a clinical investigation bronchoconstriction and its importance as a mediator in clinical asthma. Although there are in which the anticholinergic drug ipratropium bromide administered by inhalation to subjects no adenosine antagonists that have acceptance for use in humans, alternative pharmacological with stable asthma significantly attenuated the airway effects of adenosine. 38 Further support approaches have suggested that it is unlikely that adenosine acts directly on smooth muscle for a neural contribution to AMP induced bronchoconstriction comes from observations made cells in vivo, but indirectly through activation of specific receptors on intermediary in-with the loop diuretics frusemide and bumetanide. Inhalation of these drugs inhibits the flammatory cells such as mast cells or on afferent nerve endings.
bronchoconstrictor response of AMP without affecting the response to histamine. [39] [40] [41] InhalaThat mast cell derived mediators are involved in the bronchoconstrictor response to inhaled tion of loop diuretics has a similar effect on bronchoconstriction provoked by inhalation of adenosine is indicated by in vitro studies which have shown that adenosine markedly enhances sodium metabisulphite 40 and bradykinin 42 and it is believed to act by modulating sensory histamine release 16 and prostanoid generation 17 elicited from immunologically primed human nerves responses in the airways. In guinea pigs in vivo the synthetic adenosine analogue, 2-lung mast cells. Moreover, a recent study has now produced evidence that adenosine can chloroadenosine, provoked bronchoconstriction which was attenuated by capsaicin. 43 directly stimulate histamine release from human mast cells obtained by BAL. 23 But what Moreover, in BDE rats adenosine elicits increased pulmonary resistance by stimulating in vivo evidence is there to support this? The principal drugs with mast cell inhibitory prop-neuropeptide producing nerves via prior mast cell activation. 44 These observations indicate erties available for in vivo use in humans are sodium cromoglycate (SCG), nedocromil so-that release of contractile neuropeptides from sensory nerve endings might be of some importdium, and the 2 agonist, salbutamol. 24 In a series of studies conducted in asthmatic sub-ance in mediating the airway effects of purine derivatives. In support of this view, repeated jects SCG, nedocromil sodium, and salbutamol have been found to inhibit substantially AMP challenge with bradykinin sufficient to cause a 15-fold reduction in response to the kinin induced bronchoconstriction by 9.6-, 22.2-, and 26.6-fold, respectively.
25 26 In addition, results in a small attenuation of a subsequent AMP response without affecting airway repremedication with H 1 -histamine receptor antagonists 27 28 and potent inhibitors of cyclo-sponsiveness to histamine. 45 However, inhibition of NEP by inhaled phosphoramidon oxygenase and 5-lipoxygenase [29] [30] [31] [32] have been shown to inhibit the acute bronchoconstrictor failed to elicit any significant enhancement of
bronchospastic response provoked by AMP, greatest increase occurring in atopic compared with non-atopic volunteers. 36 This indicates suggesting that release of endogenous neuropeptides has little importance in the airway that atopic status is the single most important determinant of enhanced adenosine induced response to adenosine in asthma. 46 The bronchoconstrictor response to ad-histamine release and that this response may be used as an index of mast cell priming in enosine therefore involves one, or possibly two, pathways which may be abnormally active in vivo. The capacity of adenosine to augment mediator release from mast cells in the presence asthma, suggesting that it may be a more specific marker of asthma than bronchoconstrictor of a "low level" second stimulus, which may be immunological or non-immunological, challenges such as histamine and methacholine.
raises the possibility that this nucleoside elicits mediator release in asthmatic human airways by interacting with cytokine "primed" mast Airway responsiveness to adenosine as a marker of disease activity cells on the surface of inflamed airways. Thus, purine induced bronchoconstriction in asthBronchial hyperresponsiveness (BHR), the exaggerated bronchoconstrictor response to vari-matic and normal atopic subjects may well depend on the state of airway mast cell priming ous stimuli, is frequently associated with bronchial asthma. 47 The extent of this sus-and might be useful as an in vivo test for this. On the basis of these observations, we believe ceptibility has been related to the degree of airway inflammation, as reflected by the num-that adenosine bronchoprovocation may have an application in differentiating asthma from ber and state of activation of various inflammatory cells. 11 48-50 Although inflammation other diseases of the airways, and might provide an index that could be used to survey disease of asthmatic airways is often linked with BHR, the clinical and diagnostic relevance of airway progression, monitor treatment, and assess prognosis. responsiveness as currently defined is unclear. Indeed, standard bronchoprovocation tests Non-smoking adults with COPD are significantly less responsive to inhaled adenosine with inhalation of histamine or methacholine are not specific for confirming a diagnosis of than non-smoking asthmatic subjects, whereas the sensitivity to methacholine is similar in both asthma as they do not exclude chronic obstructive pulmonary disease (COPD) or other groups. 55 In children bronchoprovocation tests with inhaled adenosine discriminates asthma respiratory disorders. The relatively low specificity of histamine or methacholine broncho-from paediatric COPD with a sensitivity and specificity of 85-90%, in contrast to methaprovocation for asthma indicates that other tests might offer greater specificity. Assessment choline challenge which fails to distinguish between the two. 56 Taken together these findings of airway hyperresponsiveness with indirect bronchoconstrictor stimuli such as adenosine indicate that adenosine challenge may be a useful tool in the differential diagnosis of may fill this gap.
Confirmation of the in vivo broncho-asthma and COPD in patients of all ages in whom the diagnosis is clinically uncertain. In constrictor response in asthma has been obtained in vitro where bronchi from asthmatic addition, the specificity of adenosine bronchoprovocation for asthma, together with the high subjects were more sensitive to adenosine than those obtained from non-asthmatic controls. 51 repeatability of this test, could be useful for epidemiological studies. In this regard, adenosine may be unique since in vitro hyperresponsiveness was not dem-
The view that adenosine responsiveness may be a more robust marker of disease activity in onstrated with other mediators such as histamine and leukotriene C4. 51 In humans the relation to allergic airway inflammation than other non-specific stimuli such as histamine or airway response to inhaled adenosine is not accompanied by a late phase of broncho-methacholine is supported by a number of clinical studies. In subjects with active allergic constriction or an increase in non-specific bronchial responsiveness. 52 Responsiveness of the rhinitis we have recently shown that airways responsiveness to AMP, but not methacholine, airways to inhaled adenine derivatives correlates only weakly with more direct indices is strongly correlated to sputum eosinophilia. potential usefulness of AMP in detecting inflammatory changes in adult and paediatric Phillips et al 34 have shown that atopic subjects, when compared with non-atopic controls, asthma. These authors have demonstrated that regular treatment with inhaled corticosteroids are relatively more responsive to inhaled adenosine than they are to methacholine, in-results in a significantly greater reduction in AMP responsiveness than direct (methacholine dicating that the airway response to these purines may be an index of mast cell priming. and histamine) and neurally acting stimuli (sodium metabisulphite and bradykinin). [58] [59] [60] In this context, it is of interest that adenosine potentiates the release of inflammatory me-In keeping with this, three studies have shown that agonists cause greater bronchoprotection diators when human mast cells are immunologically primed in vitro. 16 17 Increased against AMP than histamine or methacholine challenge in patients with asthma. 26 61 62 Van adenosine responsiveness in the form of heightened histamine release has been shown in Velzen et al 63 have recently shown that improvements in clinical asthma occurred in a sensitised mice compared with non-sensitised controls.
54 Indeed, nasal challenge with AMP group of 16 allergic asthmatic children admitted to a high altitude clinic. This was beelicits rhinitic symptoms and an immediate rise in histamine levels in the lavage fluid with the lieved to be due to the lower allergen levels demiological setting and in following disease 29 Crimi N, Palermo F, Polosa R, Oliveri R, Maccarrone C, activity and response to treatment.
